Simultaneous analysis of FDG, ClDG and Kryptofix 2.2.2 in [18F]FDG preparation by high-performance liquid chromatography with UV detection

Nuclear Medicine and Biology

Volumn 35, Issue 2, 2008, Pages 239-244

  Nakao, Ryuji ^a   Ito, Takehito ^a,b   Yamaguchi, Masatoshi ^c   Suzuki, Kazutoshi ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b Sumitomo Accelerator Service   (Japan)

^c FUKUOKA UNIVERSITY   (Japan)

Author keywords

1 phenyl 3 methyl 5 pyrazolone (PMP); 18F FDG; ClDG; Kryptofix 2.2.2; Quality control

Indexed keywords

2 DEOXY 2 CHLORO DEXTRO GLUCOSE; BORIC ACID; FLUORODEOXYGLUCOSE; FLUORODEOXYGLUCOSE F 18; PYRAZOLONE DERIVATIVE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ARTICLE; DERIVATIZATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; QUALITY CONTROL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SENSITIVITY ANALYSIS; SEPARATION TECHNIQUE; TEMPERATURE; ULTRAVIOLET RADIATION;

BICYCLO COMPOUNDS, HETEROCYCLIC; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEOXYGLUCOSE; DRUG STABILITY; FLUORODEOXYGLUCOSE F18; PHARMACEUTICAL PREPARATIONS; QUALITY CONTROL; RADIOPHARMACEUTICALS; SPECTROPHOTOMETRY, ULTRAVIOLET; STEREOISOMERISM;

EID: 38849149638     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2007.11.003     Document Type: Article

References (19)

1. Fludeoxyglucose F 18 injection. The United States pharmacopeia, 27th ed., and The national formulary, 22th ed (2004), United States Pharmacopeial Convention, Inc., Rockville (MD) 815-816
2. 18F) injection. The European pharmacopeia. 4th ed. (2002), European Directorate for the Quality of the Medicines, Strasbourg, France 2316-2319
3. 18F]FDG preparations and detection of the chemical impurity 2-deoxy-2-chrolo-D-glucose. Appl Radiat Isot 43 (1992) 1313-1322
4. 18F]FDG by HPLC with UV detection. Nucl Med Biol 32 (2005) 907-912
5. Honda S., Akao E., Suzuki S., Okuda M., Kakehi K., and Nakamura J. High-performance liquid chromatography of reducing carbohydrates as strongly ultraviolet-absorbing and electrochemically sensitive 1-phenyl-3-methyl-5-pyrazolone derivatives. Anal Biochem 180 (1989) 351-357
6. Zhang L., Xu J., Zhang L., Zhang W., and Zhang Y. Determination of 1-phenyl-3-methyl-5-pyrazolone-labeled carbohydrates by liquid chromatography and micellar electrokinetic chromatography. J Chromatogr B 793 (2003) 159-165
7. Fu D., and O'Neill R.A. Monosaccharide composition analysis of oligosaccharides and glycoproteins by high-performance liquid chromatography. Anal Biochem 227 (1995) 377-384
8. Pitt J.J., and Gorman J.J. Oligosaccharide characterization and quantitation using 1-phenyl-3-methyl-5-pyrazolone derivatization and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Anal Biochem 248 (1997) 63-75
9. Hamacher K., Coenen H.H., and Stocklin G. Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 27 (1986) 235-238
10. 18F]FDG using an alkaline hydrolysis on solid support. J Labelled Compd Radiopharm 42 (1999) 515-516
11. Baudot P., Jacque M., and Robin M. Effect of a diaza-polyoxa-macrobicyclic complexing agent on the urinary elimination of lead in lead-poisoned rats. Toxicol Appl Pharmacol 41 (1977) 113-118
12. 18FDG by cation exchange. Appl Radiat Isot 42 (1989) 1189-1193
13. 18F]2-fluoro-2-deoxy-D-glucose. Nucl Med Biol 16 (1989) 385-387
14. 18FDG by gas chromatography using a nitrogen-selective detector. Nucl Med Biol 20 (1993) 367-369
15. 18F]FDG preparations. Nucl Med Biol 24 (1997) 193-195
16. 18F]FDG and other radiopharmaceuticals by LC/MS/MS. Nucl Med Biol 29 (2002) 125-129
17. 18F]FDG injection: bacterial endotoxins test, aluminum ions test and HPLC analysis for FDG and CIDG K. Appl Radiat Isot 62 (2005) 889-895
18. 34mCl]chloro-2-deoxy-glucose in rat. J Labelled Compd Radiopharm 48 (2005) S159
19. MacNair J.E., Lewis K.C., and Jorgenson J.W. Ultrahigh-pressure reversed-phase liquid chromatography in packed capillary columns. Anal Chem 69 (1997) 983-989